Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Foreword
  • Published:

Therapeutic antibodies: past, present and future

Nature Reviews Immunology volume 10, page 297 (2010)Cite this article

Subjects

Abstract

Over the past 10 years, the market for monoclonal antibodies has grown exponentially. This focus issue brings together articles on the basic biology of antibodies and their therapeutic use, providing an overview of the latest prospects and continued challenges for the development of safe, efficient and affordable therapeutic antibodies.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Aggarwal, S. Nature Biotech. 11, 987–993 (2009).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Senior Editor, Nature Reviews Immunology,

    Olive Leavy

Authors
  1. Olive Leavy
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leavy, O. Therapeutic antibodies: past, present and future. Nat Rev Immunol 10, 297 (2010). https://doi.org/10.1038/nri2763

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nri2763

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing